A phase I/II first-line study of R-CHOP plus B-cell receptor/NF-KB-double-targeting to moleculary assess therapy response

Sophy Denker, Aitomi Bittner, Il-Kang Na, Julia Kase, Mareike Frick, Ioannis Anagnostopoulos, Michael Hummel, Clemens Schmitt

Research output: Contribution to journalArticlepeer-review

Original languageGerman (Austria)
Number of pages1
JournalInternational Journal of Hematologic Oncology
Volume8
Issue number4
DOIs
Publication statusPublished - Dec 2019

Fields of science

  • 302 Clinical Medicine

Cite this